Analysis of clinical efficacy of neoadjuvant chemotherapy in patients with locally advanced cervical cancer
10.3760/cma.j.issn.1008-6706.2013.05.029
- VernacularTitle:新辅助化疗治疗局部晚期宫颈癌疗效分析
- Author:
Xia YU
;
Xiaomin XIE
;
Liwu ZHANG
- Publication Type:Journal Article
- Keywords:
Neoadjuvant chemotherapy;
Locally advanced cervical cancer;
Tumor volume;
Transfer
- From:
Chinese Journal of Primary Medicine and Pharmacy
2013;20(5):708-710
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects and clinical value of neoadjuvant chemotherapy in patients with locally advanced cervical cancer.Methods 102 cases with locally advanced cervical cancer treated were randomly divided into observation group and control group,the observation group received the surgery after the neoadjuvant chemotherapy,and the control group was given a direct surgical treatment.Operative time,blood loss and postoperative pathologic results were observed,and chemotherapy and toxicity evaluation were made for the observation group.Results The chemotherapy effective rate of the observation group was 74.51％,and the toxicity could be tolerated;the operation time and blood loss of the observation group were significantly lower than those of the control group(all P ＜ 0.05) ;surgical trauma and postoperative complications' occurrence rate of the observation group were significantly lower than those of the control group (all P ＜ 0.05) ; pelvic lymph node metastasis and vaginal cutting edge of the residues of the observation group were significantly lower than those of the control group (all P ＜ 0.05).Conclusion For locally advanced cervical cancer,NACT has a positive significance in reducing the tumor volume,low-er tumor stage,and at the same time reducing the difficulty of operation,surgical trauma,postoperative complications,and preventing recurrence and metastasis,which can be used as a better adjuvant treatment program for locally advanced cervical cancer.
